Lilly Faces HSBC Sell Rating Amid Weight Loss Drug Price Cut Expectations
HSBC issued a lone sell rating for Eli Lilly (Lilly) ahead of anticipated price cuts for weight loss drugs. The move comes as competition intensifies in the weight loss drug market.